📊 Detect, Diagnose, Defend: Protecting the Heart During ICI Therapy per IC-OS 🫀🧭🛡️

🚀 Immune checkpoint inhibitors have transformed cancer care—but they come with a cardiovascular shadow. A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. 🫀💡   Key insights include: • Early recognition with troponin, ECG, and CMR 🧪📊 • Smoldering vs. nonsevere vs. fulminant myocarditis distinctions 🔍 • Steroid-first management and the evolving role of abatacept + JAK inhibitors 💊 • Nuanced approaches to ICI rechallenge when cancer control demands it 🔄🎯 • The essential role of multidisciplinary cardio-oncology teams 🤝   This is a must-read for anyone navigating the intersection of oncology, cardiology, and immunotherapy. 🌐🔥